Semaglutide (Compounded)
Same molecule as Wegovy/Ozempic, compounded form (now FDA-restricted in US).
Scientific Overview
Semaglutide compounded was widely distributed 2022-Apr/May 2025. FDA ended both 503A (Apr 22 2025) and 503B (May 22 2025) discretion.
Key Research Benefits
- ✓Weight loss
- ✓CV protection (in approved use)
- ✓Cost savings vs brand
Potential Side Effects
Research Protocols
Common DosagesPer-protocol
“Same titration as Wegovy”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.10 mL on a U-100 syringe
Explore Semaglutide (Compounded)
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Semaglutide (Compounded) by goal
Read Semaglutide (Compounded)'s profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Metabolic
- Common Dosage
- 0.25 → 2.4 mg
- Weekly
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.